Record overview
Status and phase
Status: RECRUITING
Phase: PHASE1, PHASE2
Sponsor: Aminex Therapeutics, Inc.
Condition: Melanoma (Skin Cancer), HER2-low Hormone Receptor Positive Breast Cancer
NCT07287917
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: None
Results signal: Low Signal
Operational burden: rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.